LysB

UniProt ID: Q08694
Organism: Drosophila melanogaster
Review Status: DRAFT
πŸ“ Provide Detailed Feedback

Gene Description

LysB encodes Lysozyme B, a secreted c-type lysozyme (glycosyl hydrolase family 22) that hydrolyzes the beta-1,4 glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine in bacterial peptidoglycan. Unlike classical immune lysozymes that function in the hemolymph, LysB is primarily expressed in the digestive tract (midgut of larvae and adults) where it functions in the digestion of bacteria from food and in shaping gut microbiota composition. LysB is not expressed in fat body or hemocytes and is actually repressed, not induced, upon systemic bacterial infection, supporting its role as a digestive rather than immune enzyme (PMID:8159165, Marra et al. 2021).

Proposed New Ontology Terms

digestion of microorganism

Definition: The process of breaking down microorganisms (bacteria, fungi, etc.) as food or for nutrient acquisition, typically through enzymatic degradation in the digestive tract. This process is distinct from immune-mediated killing of microorganisms.

Justification: There is currently no GO term specifically for the enzymatic digestion of bacteria/microorganisms as food or for microbiota regulation. This would be distinct from immune-mediated killing. Terms like "digestion" are broad, and "defense response to bacterium" implies immune function. A term capturing the digestive/symbiotic processing of bacteria would better annotate genes like LysB.

Parent term: digestion

Existing Annotations Review

GO Term Evidence Action Reason
GO:0003796 lysozyme activity
IBA
GO_REF:0000033
ACCEPT
Summary: LysB is a bona fide c-type lysozyme belonging to glycosyl hydrolase family 22, with conserved catalytic residues and characteristic domain structure. The IBA annotation is based on phylogenetic inference from well-characterized lysozymes including chicken lysozyme (UniProtKB:P00698). The enzymatic activity is supported by the conserved catalytic Glu/Asp residues (positions 50 and 68 in LysB) and demonstrated ex vivo lysozyme activity in gut extracts from Drosophila (Marra et al. 2021).
Reason: Core molecular function of LysB. The GH22 family assignment, conserved catalytic residues, and functional validation through gut lysozyme activity assays all support this annotation. IBA provides strong phylogenetic evidence.
Supporting Evidence:
PMID:8159165
four closely related genes, LysB, C, D and E, are all strongly expressed in the midgut of larvae and adults
file:DROME/LysB/LysB-deep-research-falcon.md
engineered deletion (LysB-PD) removing LysC and four gut-expressed lysozyme genes (including LysB) reduced ex vivo lysozyme activity (peptidoglycan digestion)
GO:0003796 lysozyme activity
IEA
GO_REF:0000120
ACCEPT
Summary: This IEA annotation is based on InterPro domain mapping (IPR000974) and EC number assignment (EC:3.2.1.17). It correctly identifies LysB as having lysozyme (1,4-beta-N-acetylmuramidase) activity.
Reason: Redundant with IBA annotation but correctly assigned based on domain architecture. The InterPro glycosyl hydrolase 22 domains (IPR001916, IPR000974) and EC:3.2.1.17 assignment are accurate for this protein.
Supporting Evidence:
UniProt:Q08694
Belongs to the glycosyl hydrolase 22 family
GO:0003824 catalytic activity
IEA
GO_REF:0000043
ACCEPT
Summary: This is a very general parent term for lysozyme activity. While technically correct, it provides no additional information beyond what is captured by the more specific lysozyme activity annotation.
Reason: Automatically inferred from UniProtKB keyword mapping. While overly general, this hierarchical annotation is not incorrect and serves as a parent term for the more informative lysozyme activity annotations.
Supporting Evidence:
UniProt:Q08694
RecName: Full=Lysozyme B; EC=3.2.1.17
GO:0016787 hydrolase activity
IEA
GO_REF:0000043
ACCEPT
Summary: Parent term annotation derived from hydrolase keyword. LysB is indeed a hydrolase that cleaves glycosidic bonds in peptidoglycan.
Reason: Correct hierarchical annotation. More specific terms (lysozyme activity, hydrolase activity acting on glycosyl bonds) are also present.
Supporting Evidence:
UniProt:Q08694
Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan
GO:0016798 hydrolase activity, acting on glycosyl bonds
IEA
GO_REF:0000043
ACCEPT
Summary: Appropriately specific parent term for lysozyme activity. LysB hydrolyzes glycosyl bonds in bacterial peptidoglycan.
Reason: Correct intermediate-level annotation. This is the appropriate parent for lysozyme activity (GO:0003796) and accurately describes the bond type cleaved.
Supporting Evidence:
UniProt:Q08694
Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan
GO:0031640 killing of cells of another organism
IEA
GO_REF:0000043
ACCEPT
Summary: This annotation is derived from the UniProtKB Antimicrobial keyword (KW-0081). While lysozymes can technically kill bacteria by degrading their cell walls, this annotation requires careful evaluation for LysB specifically. The primary literature (PMID:8159165) explicitly states that LysB is "unlikely to play an active role in the humoral immune defense" and is adapted for "digestion of bacteria in the food." The deep research shows LysB functions in gut microbiota regulation rather than bactericidal immunity. However, lysozyme-mediated peptidoglycan hydrolysis does result in bacterial cell death, making this annotation technically accurate even for digestive lysozymes. This represents a legitimate SPKW annotation for lysozymes.
Reason: This is a LEGITIMATE SPKW annotation for lysozymes. While the primary biological role of LysB is digestive/microbiota regulation rather than immune defense, the enzymatic action of lysozyme (peptidoglycan hydrolysis) does result in bacterial cell killing. The annotation captures the molecular outcome of lysozyme activity. The UniProt Antimicrobial keyword is appropriately applied to bacteriolytic enzymes. This is an example of correct SPKW contribution where the keyword accurately reflects the biochemical consequence of enzyme activity.
Supporting Evidence:
PMID:8159165
probably involved in the digestion of bacteria in the food
UniProt:Q08694
Antimicrobial; Bacteriolytic enzyme
GO:0042742 defense response to bacterium
IEA
GO_REF:0000043
MODIFY
Summary: This annotation is derived from the Antimicrobial keyword. However, the primary literature strongly suggests LysB does NOT function in classical immune defense. PMID:8159165 states LysB is "unlikely to play an active role in the humoral immune defense" and is not expressed in immune tissues (fat body, hemocytes). Furthermore, LysB and related gut lysozymes are REPRESSED, not induced, after systemic bacterial infection. The Marra et al. 2021 study shows gut lysozymes function in microbiota regulation and homeostasis rather than pathogen defense. While lysozymes can contribute to defense by killing bacteria, the specific biological context of LysB is digestive/homeostatic rather than defensive.
Reason: This annotation may overstate the immune defense role of LysB. The literature explicitly indicates LysB is adapted for digestive function and is not part of the humoral immune response. Consider whether a more accurate process annotation would capture the microbiota regulation function. However, there is no ideal GO term for "digestion of bacteria" or "gut microbiota regulation by enzyme." The term could be retained with the understanding that it represents a broader interpretation, but marking as potentially over-annotated.
Proposed replacements: digestion
Supporting Evidence:
UniProt:Q08694
Unlikely to play an active role in the humoral immune defense. May have a function in the digestion of bacteria in the food.
PMID:8159165
The LysD-like genes and LysS are strongly repressed in artificially infected animals
PMID:8159165
None of the genes is expressed in the fat body or haemocytes
GO:0003796 lysozyme activity
ISS
GO_REF:0000024
ACCEPT
Summary: ISS annotation based on sequence similarity to characterized lysozymes, using UniProtKB:P00697 (turkey lysozyme) as reference. This supports the enzymatic function annotation.
Reason: Valid ISS annotation supporting the core molecular function. The sequence similarity to well-characterized vertebrate lysozymes is well-established.
Supporting Evidence:
UniProt:Q08694
Belongs to the glycosyl hydrolase 22 family
GO:0005615 extracellular space
ISS
GO_REF:0000024
ACCEPT
Summary: ISS annotation indicating extracellular localization. This is consistent with LysB being a secreted protein with a signal peptide (residues 1-18). The protein is predicted to be secreted into the gut lumen where it acts on bacteria.
Reason: Appropriate cellular component annotation. LysB has a signal peptide and is secreted. Expression in midgut and detection in haemolymph at low levels support extracellular localization (PMID:8159165). For a gut lysozyme, the extracellular space would be the gut lumen.
Supporting Evidence:
file:DROME/LysB/LysB-deep-research-falcon.md
Insect c-type lysozymes are secreted proteins with N-terminal signal peptides
UniProt:Q08694
AltName: Full=1,4-beta-N-acetylmuramidase B; Flags: Precursor
GO:0050829 defense response to Gram-negative bacterium
ISS
GO_REF:0000024
MODIFY
Summary: ISS annotation based on similarity to vertebrate lysozymes. This is problematic for several reasons. First, LysB is unlikely to function in immune defense as stated explicitly in PMID:8159165. Second, classical c-type lysozymes are typically more effective against Gram-positive bacteria (which have exposed peptidoglycan) than Gram-negative bacteria (which have an outer membrane protecting the peptidoglycan layer). The annotation may be transferred from a vertebrate lysozyme in a different functional context.
Reason: This annotation is likely inappropriate for LysB. The literature indicates LysB is not an immune defense protein. Additionally, classical lysozymes require outer membrane permeabilization to act on Gram-negative bacteria. If a defense annotation is retained, it should be at the more general "defense response to bacterium" level, though even that is questionable given the explicit statements in the primary literature that LysB does not function in immune defense.
Proposed replacements: digestion
Supporting Evidence:
UniProt:Q08694
Unlikely to play an active role in the humoral immune defense. May have a function in the digestion of bacteria in the food.
PMID:8159165
None of the genes is expressed in the fat body or haemocytes
GO:0003796 lysozyme activity
ISS
PMID:8159165
The lysozyme locus in Drosophila melanogaster: an expanded g...
ACCEPT
Summary: This annotation cites PMID:8159165 (Daffre et al. 1994) which characterized the Drosophila lysozyme gene family. While the paper establishes that LysB is a lysozyme gene in the 61F locus, it primarily characterizes expression patterns rather than providing direct enzymatic assays for LysB specifically. However, the sequence analysis and family membership strongly support lysozyme activity.
Reason: Core molecular function annotation supported by the primary characterization paper. The paper establishes LysB as part of an expanded lysozyme gene family with digestive tract expression.
Supporting Evidence:
PMID:8159165
four closely related genes, LysB, C, D and E, are all strongly expressed in the midgut of larvae and adults

Core Functions

LysB is a c-type lysozyme (GH22 family) that hydrolyzes beta-1,4 glycosidic bonds between N-acetylmuramic acid and N-acetylglucosamine in bacterial peptidoglycan. It is expressed in the midgut where it functions in digestion of bacteria from food and regulation of gut microbiota composition.

Molecular Function:
lysozyme activity
Directly Involved In:
Cellular Locations:
Supporting Evidence:
  • PMID:8159165
    four closely related genes, LysB, C, D and E, are all strongly expressed in the midgut of larvae and adults
  • UniProt:Q08694
    May have a function in the digestion of bacteria in the food

References

The lysozyme locus in Drosophila melanogaster: an expanded gene family adapted for expression in the digestive tract.
  • LysB is one of seven lysozyme genes at the 61F locus
    "we have now characterized all six lysozyme genes in the cloned part of the lysozyme locus at 61F, and a seventh gene that maps to the same chromosomal location"
  • LysB, LysC, LysD, and LysE are strongly expressed in midgut of larvae and adults
    "four closely related genes, LysB, C, D and E, are all strongly expressed in the midgut of larvae and adults"
  • None of the lysozyme genes is expressed in fat body or hemocytes
    "None of the genes is expressed in the fat body or haemocytes"
  • LysD-like genes are repressed after systemic bacterial infection
    "The LysD-like genes and LysS are strongly repressed in artificially infected animals"
  • The lysozymes are unlikely to play a role in humoral immune defense
    "rather than being a component of the haemolymph, the Drosophila lysozymes are found mainly in the digestive tract"
  • The function is probably digestion of bacteria in food
    "probably involved in the digestion of bacteria in the food"
  • All genes except LysP encode acidic proteins (unlike typical basic lysozymes)
    "Furthermore all genes, except LysP, encode acidic proteins, in contrast to the strongly basic "typical" lysozymes"
  • Expression pattern is reminiscent of ruminant stomach lysozymes that digest symbiotic bacteria
    "highly reminiscent of the situation in ruminants, where the lysozymes have been recruited for the digestion of symbiotic bacteria in the stomach"
file:DROME/LysB/LysB-deep-research-falcon.md
Deep research summary for LysB from Falcon AI
  • Deletion of gut lysozymes (LysB-PD) reduces ex vivo muramidase activity
    "engineered deletion (LysB-PD) removing LysC and four gut-expressed lysozyme genes (including LysB) reduced ex vivo lysozyme activity (peptidoglycan digestion)"
  • Lysozyme loss increases stochasticity of gut microbiota composition
    "loss of lysozymes (LysB-PD deletion removing LysB, LysD, LysE, LysP, LysC) increased stochasticity and altered community structure"
  • Total bacterial load is not significantly affected by lysozyme loss
    "total bacterial load changes were not significant, indicating lysozymes contribute primarily to composition control rather than bulk bacterial burden"
  • Lysozymes contribute to microbiota community structure regulation
    "lysozymes, while secondary to AMPs in effect size, are necessary to stabilize gut community structure"
  • Gut lysozymes are induced by microbiota colonization (not systemic infection)
    "gut colonization by microbiota induces gut lysozyme expression, aligning them with epithelial homeostasis rather than systemic acute-phase effectors"
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  • Maps Antimicrobial keyword (KW-0081) to GO:0031640 (killing of cells of another organism)
  • Maps Antimicrobial keyword to GO:0042742 (defense response to bacterium)
  • Maps Hydrolase keyword to GO:0016787 and children
Combined Automated Annotation using Multiple IEA Methods

Suggested Questions for Experts

Q: What is the relative contribution of individual lysozyme genes (LysB, LysC, LysD, LysE) to gut function?

Q: Does LysB have any role in host defense in specific contexts (e.g., gut epithelial immunity)?

Q: What is the substrate specificity of LysB - is it more effective against certain bacterial species?

Suggested Experiments

Experiment: Single-gene CRISPR knockout of LysB to distinguish its function from other gut lysozymes

Hypothesis: LysB knockout alone will have measurable effects on gut microbiota composition

Experiment: Direct enzymatic assays with purified LysB protein against different bacterial peptidoglycans

Hypothesis: LysB will show muramidase activity with potential substrate preferences

Experiment: Comparison of LysB activity at acidic gut pH vs neutral pH

Hypothesis: LysB may have optimal activity at gut pH consistent with its digestive role

Deep Research

Falcon

(LysB-deep-research-falcon.md)
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate. Falcon Edison Scientific Literature 14 citations 2026-01-30T21:00:00.554626

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan overview
We verified identity and gathered Drosophila-focused primary and recent review evidence on Lysozyme B (LysB/CG1179; UniProt Q08694), prioritized 2021–2024 sources, and compiled mechanistic, localization, regulatory, and quantitative details. We highlight what is specific to LysB versus the gut lysozyme cluster.

Comprehensive research report: Drosophila melanogaster LysB (Lysozyme B, CG1179; UniProt Q08694)

1) Key concepts and definitions
- Molecular identity and family: LysB encodes a c-type/GH22 lysozyme (EC 3.2.1.17) that hydrolyzes the Ξ²-1,4 glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine in bacterial peptidoglycan (PGN), classically active against Gram-positive PGN and also acting on Gram-negative PGN after outer-membrane permeabilization. Insect c-type lysozymes share conserved catalytic Glu/Asp residues and disulfide-stabilized LYZ1 domains, and are typically secreted proteins with signal peptides (cross-species inference) (huang2021identificationandfunctional pages 5-7). In Drosophila, lysozymes constitute an expanded family with multiple gut-expressed members, including LysB (daffre2004thelysozymelocus pages 1-2, marra2021drosophilaantimicrobialpeptides pages 2-4).
- Gene family organization: A cluster of lysozyme genes at cytological 61F contains several gut-enriched paralogs (LysB, LysC, LysD, LysE, LysP, LysS, LysX). Daffre et al. mapped and characterized seven lysozyme genes at or near 61F, with strong digestive-tract expression of LysB/C/D/E (daffre2004thelysozymelocus pages 1-2, daffre2004thelysozymelocus pages 8-9). Marra et al. later note at least ~17 putative lysozyme genes genome-wide, with a defined gut cluster including LysB (marra2021drosophilaantimicrobialpeptides pages 2-4).

2) Biochemical function and substrate specificity
- Enzymatic activity: As a GH22 muramidase, the LysB product hydrolyzes the glycan backbone of PGN; canonical c-type lysozymes rely on catalytic Glu/Asp residues and show activity in turbidimetric assays against Micrococcus luteus cell walls and in peptidoglycan digestion assays (methodological benchmark; cross-species but directly applicable to Drosophila lysozymes) (huang2021identificationandfunctional pages 5-7). In Drosophila gut tissue, lysozyme activity can be measured ex vivo: Marra et al. demonstrated reduced lysozyme activity of gut extracts from a deletion mutant that removes LysB together with other gut lysozymes by assaying Enterococcus faecalis PGN digestion, supporting functional muramidase activity of the cluster including LysB (marra2021drosophilaantimicrobialpeptides pages 2-4).

3) Cellular localization and site of action
- Tissue expression and cellular localization: Drosophila lysozymes, including LysB, are predominantly expressed in the digestive tract (larval and adult midgut), rather than in immune tissues like fat body or hemocytes. Daffre et al. detected strong midgut expression of LysB/C/D/E and did not detect expression in fat body or hemocytes; lysozymes were detectable in the haemolymph at low levels, consistent with secreted proteins originating from epithelia (daffre2004thelysozymelocus pages 1-2, daffre2004thelysozymelocus pages 8-9). Contemporary work corroborates gut expression of the lysozyme cluster and expression upon microbiota colonization (marra2021drosophilaantimicrobialpeptides pages 2-4).
- Secreted effector: Insect c-type lysozymes are secreted proteins with N-terminal signal peptides; secretion to the gut lumen is consistent with the digestive-tract expression pattern and ex vivo activity from gut extracts (cross-species structural inference combined with Drosophila ex vivo activity evidence) (huang2021identificationandfunctional pages 5-7, marra2021drosophilaantimicrobialpeptides pages 2-4).

4) Biological role and pathways
- Primary function in vivo: Regulation of gut microbiota composition and abundance. Using gnotobiotic flies colonized with a defined community, Marra et al. showed that loss of gut lysozymes (LysB-PD deletion removing LysB, LysD, LysE, LysP, LysC) increased stochasticity and altered community structure; total bacterial load changes were not significant, indicating lysozymes contribute primarily to composition control rather than bulk bacterial burden (marra2021drosophilaantimicrobialpeptides pages 2-4, marra2021drosophilaantimicrobialpeptides pages 4-7).
- Pathway context and sensing: In the Drosophila gut, PGN sensing via PGRP-LE and activation of the IMD/NF-ΞΊB pathway are central to antibacterial responses; lysozymes and AMPs are epithelial effectors that act downstream to shape the microbiota and limit dysbiosis. Reviews summarizing recent advances emphasize IMD dominance in the midgut and note lysozymes as part of the gut antimicrobial repertoire; Toll roles in the midgut are limited compared to IMD, though Toll has broader roles in systemic immunity (zhou2024insectantimicrobialpeptides pages 19-21, marra2021drosophilaantimicrobialpeptides pages 4-7). Lysozymes may also modulate IMD signaling by cleaving PGN fragments that alter PGRP detection thresholds (proposed in Marra et al.) (marra2021drosophilaantimicrobialpeptides pages 2-4).
- Regulation and infection response: Classic work indicates that several gut lysozymes can be repressed, not induced, after systemic bacterial injection, highlighting their digestive specialization rather than systemic immune inducibility (daffre2004thelysozymelocus pages 1-2, daffre2004thelysozymelocus pages 8-9). In contrast, gut colonization by microbiota induces gut lysozyme expression, aligning them with epithelial homeostasis rather than systemic acute-phase effectors (marra2021drosophilaantimicrobialpeptides pages 2-4).

5) Recent developments and latest research (prioritizing 2023–2024)
- Contemporary reviews (2024) integrate lysozymes with AMPs as key epithelial effectors that maintain gut microbial homeostasis, regulated by IMD and PGN sensing in Drosophila; they highlight PGRP-LE mediated detection and the importance of epithelial effectors in microbiota control and tolerance (zhou2024insectantimicrobialpeptides pages 19-21). These syntheses reaffirm the model where lysozymes like LysB contribute to homeostatic control rather than broad systemic bactericidal responses (zhou2024insectantimicrobialpeptides pages 19-21).

6) Current applications and real-world implementations
- Methodological applications: The Drosophila gut provides a tractable system for dissecting lysozyme function in host–microbe interactions. The lysozyme deletion (LysB-PD) provides a genetic tool to parse effector roles in microbial ecology and aging-related dysbiosis, applicable to microbiome research and innate immunity modeling (marra2021drosophilaantimicrobialpeptides pages 2-4). Standard muramidase assays and PGN digestion readouts used in insects provide robust functional validation platforms that can be adapted for Drosophila lysozymes (huang2021identificationandfunctional pages 5-7, marra2021drosophilaantimicrobialpeptides pages 2-4).

7) Expert opinions and analysis from authoritative sources
- Primary and integrative viewpoints: Marra et al. (mBio) argue that lysozymes, while secondary to AMPs in effect size, are necessary to stabilize gut community structure; their loss increases stochasticity and susceptibility to dysbiosis during aging (marra2021drosophilaantimicrobialpeptides pages 2-4, marra2021drosophilaantimicrobialpeptides pages 4-7). The 2024 review frames lysozymes together with AMPs as guardians of gut homeostasis under IMD control, consistent with modern views of epithelial immunity prioritizing tolerance and community structuring over sterilization (zhou2024insectantimicrobialpeptides pages 19-21).

8) Relevant statistics and data
- Gene family counts and genomic context: At least seven lysozymes defined at/near 61F with digestive-tract expression (1993/2004 mapping), and later work suggests ~17 putative lysozymes genome-wide (daffre2004thelysozymelocus pages 1-2, daffre2004thelysozymelocus pages 8-9, marra2021drosophilaantimicrobialpeptides pages 2-4).
- Functional assays: The lysozyme-cluster deletion (LysB-PD) reduced ex vivo muramidase activity of gut extracts against Enterococcus faecalis PGN; in gnotobiotic flies, loss of lysozymes increased variance/stochasticity of community composition, with examples such as Lactobacillus brevis dominance in individual samples; total bacterial load by 16S copies was not significantly different across genotypes (marra2021drosophilaantimicrobialpeptides pages 2-4, marra2021drosophilaantimicrobialpeptides pages 4-7).
- Induction/repression patterns: Daffre et al. reported that several gut lysozyme transcripts (e.g., LysS and LysD-like genes that include LysB/C/D/E) are repressed after systemic bacterial injection, while gut colonization induces expression locally (qualitative patterns) (daffre2004thelysozymelocus pages 1-2, daffre2004thelysozymelocus pages 8-9, marra2021drosophilaantimicrobialpeptides pages 2-4).

9) Ambiguity check and gene verification
- The gene symbol LysB in Drosophila melanogaster refers to Lysozyme B in the 61F gut lysozyme cluster and matches UniProt Q08694 description (GH22 lysozyme; EC 3.2.1.17). Literature consistently places LysB among gut-expressed lysozymes; no conflicting Drosophila gene with the same symbol was identified in these sources (daffre2004thelysozymelocus pages 1-2, marra2021drosophilaantimicrobialpeptides pages 2-4).

10) Evidence-informed functional annotation for LysB (UniProt Q08694)
- Primary function: Secreted GH22 muramidase operating in the gut lumen to digest bacterial PGN and shape the gut microbiota; contributes to community composition control with modest effects on total bacterial load (marra2021drosophilaantimicrobialpeptides pages 2-4, marra2021drosophilaantimicrobialpeptides pages 4-7, huang2021identificationandfunctional pages 5-7).
- Site of action: Larval and adult midgut epithelia; not detectably expressed in fat body or hemocytes in classic assays (daffre2004thelysozymelocus pages 1-2, daffre2004thelysozymelocus pages 8-9).
- Pathways: Acts downstream of epithelial PGN sensing and IMD pathway activity; may influence IMD signaling through PGN cleavage products (marra2021drosophilaantimicrobialpeptides pages 2-4, zhou2024insectantimicrobialpeptides pages 19-21).
- Experimental support: Genetic deletion removing LysB with nearby gut lysozymes decreases gut muramidase activity and perturbs microbiota structure in gnotobiotic models; historic mapping and expression studies localize LysB to the digestive tract (marra2021drosophilaantimicrobialpeptides pages 2-4, daffre2004thelysozymelocus pages 1-2, daffre2004thelysozymelocus pages 8-9).

URLs and publication dates
- Daffre et al., Mol Gen Genet MGG, Jan 2004. The lysozyme locus in Drosophila melanogaster. URL: https://doi.org/10.1007/bf00391008 (daffre2004thelysozymelocus pages 1-2, daffre2004thelysozymelocus pages 8-9)
- Marra et al., mBio, Aug 2021. Drosophila AMPs and lysozymes regulate gut microbiota composition and abundance. URL: https://doi.org/10.1128/mbio.00824-21 (marra2021drosophilaantimicrobialpeptides pages 2-4, marra2021drosophilaantimicrobialpeptides pages 4-7)
- Zhou et al., International Journal of Molecular Sciences, Mar 2024. Insect antimicrobial peptides as guardians of immunity and beyond: A review. URL: https://doi.org/10.3390/ijms25073835 (zhou2024insectantimicrobialpeptides pages 19-21)
- Huang et al., Biology (MDPI), Apr 2021. Identification and Functional Analysis of a Lysozyme Gene from Coridius chinensis (cross-species mechanistic details/assays). URL: https://doi.org/10.3390/biology10040330 (huang2021identificationandfunctional pages 5-7)

Embedded evidence summary table
| Claim/Topic | Key Evidence/Result | Species/Context | Year | Source (journal) | URL/DOI |
|---|---|---:|---:|---|---|
| Lysozyme locus expansion at 61F; LysB among gut-expressed; lack of fat body/haemocyte expression; repression after bacterial injection | Four closely related genes (LysB, LysC, LysD, LysE) strongly expressed in larval/adult midgut; LysP, LysS, LysX show distinct digestive-tract expression; none detected in fat body or haemocytes; some gut lysozyme transcripts are repressed after bacterial injection | Drosophila melanogaster (digestive tract) | 2004 | Molecular and General Genetics (MGG) (daffre2004thelysozymelocus pages 1-2) | https://doi.org/10.1007/bf00391008 |
| Lysozyme family (~17 genes); gut cluster (LysB, LysD, LysE, LysP, LysS, LysX); LysB-PD deletion phenotype | Reported ~17 putative lysozymes; clustered gut lysozymes; engineered deletion (LysB-PD) removing LysC and four gut-expressed lysozyme genes (including LysB) reduced ex vivo lysozyme activity (peptidoglycan digestion) and increased stochasticity of gut microbiota composition in gnotobiotic flies; total bacterial load not significantly changed β€” lysozymes expressed upon microbiota colonization and may modulate IMD via peptidoglycan cleavage | Drosophila melanogaster (gnotobiotic gut experiments; aging contexts) | 2021 | mBio (marra2021drosophilaantimicrobialpeptides pages 2-4) | https://doi.org/10.1128/mbio.00824-21 |
| Lysozymes as gut effectors working with AMPs; immunity pathways and sensing (review) | Review synthesis: lysozymes act with antimicrobial peptides to regulate gut homeostasis; IMD (and in some contexts Toll) pathways and PGRP-mediated peptidoglycan sensing govern gut immune responses; highlights recent developments in insect gut immunity | Insects (review with Drosophila examples) | 2024 | International Journal of Molecular Sciences (IJMS) (zhou2024insectantimicrobialpeptides pages 19-21) | https://doi.org/10.3390/ijms25073835 |
| Cross-species methodological and mechanistic details for c-type insect lysozymes (inference applicable to Drosophila LysB) | Characteristic c-type features: signal peptide (secreted), conserved catalytic residues Glu/Asp (e.g., E32/D50), disulfide bonds; standard assays: turbidimetric muramidase assays using Micrococcus luteus, agar-diffusion antibacterial assays, qPCR for expression; methods transferable to study Drosophila LysB | Coridius chinensis (c-type insect lysozyme) β€” inference applicable to insect c-type lysozymes incl. Drosophila | 2021 | Biology (MDPI) (huang2021identificationandfunctional pages 5-7) | https://doi.org/10.3390/biology10040330 |

Table: Concise, sourced evidence summarizing key claims about Drosophila Lysozyme B (LysB/clustered gut lysozymes), experimental phenotypes, regulatory context, and cross-species methodological details; useful for quickly locating primary sources and their main results.

Limitations and open needs
- LysB-specific biochemical kinetics, precise catalytic residue assignments for the D. melanogaster protein, and LysB-only mutant phenotypes (separable from nearby lysozymes) were not resolved in the available sources. Current functional inferences rely on the gut cluster deletion that includes LysB and on conserved GH22 biochemistry from insect lysozymes (marra2021drosophilaantimicrobialpeptides pages 2-4, huang2021identificationandfunctional pages 5-7). Focused LysB single-gene knockout or CRISPR tagging studies would sharpen mechanistic and localization details.

Citations
- Daffre et al., 2004 (Mol Gen Genet MGG) (daffre2004thelysozymelocus pages 1-2, daffre2004thelysozymelocus pages 8-9)
- Marra et al., 2021 (mBio) (marra2021drosophilaantimicrobialpeptides pages 2-4, marra2021drosophilaantimicrobialpeptides pages 4-7)
- Zhou et al., 2024 (IJMS review) (zhou2024insectantimicrobialpeptides pages 19-21)
- Huang et al., 2021 (Biology; cross-species lysozyme characterization) (huang2021identificationandfunctional pages 5-7)

References

  1. (huang2021identificationandfunctional pages 5-7): Hai Huang, Juan Du, Shang-Wei Li, and Tao Gong. Identification and functional analysis of a lysozyme gene from coridius chinensis (hemiptera: dinidoridae). Biology, 10:330, Apr 2021. URL: https://doi.org/10.3390/biology10040330, doi:10.3390/biology10040330. This article has 10 citations and is from a poor quality or predatory journal.

  2. (daffre2004thelysozymelocus pages 1-2): Sirlei Daffre, Per Kylsten, Christos Samakovlis, and Dan Hultmark. The lysozyme locus in drosophila melanogaster: an expanded gene family adapted for expression in the digestive tract. Molecular and General Genetics MGG, 242:152-162, Jan 2004. URL: https://doi.org/10.1007/bf00391008, doi:10.1007/bf00391008. This article has 232 citations.

  3. (marra2021drosophilaantimicrobialpeptides pages 2-4): A. Marra, M. A. Hanson, S. Kondo, B. Erkosar, and B. Lemaitre. drosophila antimicrobial peptides and lysozymes regulate gut microbiota composition and abundance. mBio, Aug 2021. URL: https://doi.org/10.1128/mbio.00824-21, doi:10.1128/mbio.00824-21. This article has 143 citations and is from a domain leading peer-reviewed journal.

  4. (daffre2004thelysozymelocus pages 8-9): Sirlei Daffre, Per Kylsten, Christos Samakovlis, and Dan Hultmark. The lysozyme locus in drosophila melanogaster: an expanded gene family adapted for expression in the digestive tract. Molecular and General Genetics MGG, 242:152-162, Jan 2004. URL: https://doi.org/10.1007/bf00391008, doi:10.1007/bf00391008. This article has 232 citations.

  5. (marra2021drosophilaantimicrobialpeptides pages 4-7): A. Marra, M. A. Hanson, S. Kondo, B. Erkosar, and B. Lemaitre. drosophila antimicrobial peptides and lysozymes regulate gut microbiota composition and abundance. mBio, Aug 2021. URL: https://doi.org/10.1128/mbio.00824-21, doi:10.1128/mbio.00824-21. This article has 143 citations and is from a domain leading peer-reviewed journal.

  6. (zhou2024insectantimicrobialpeptides pages 19-21): Lizhen Zhou, Guanliang Meng, Ling Zhu, Li Ma, and Kangkang Chen. Insect antimicrobial peptides as guardians of immunity and beyond: a review. International Journal of Molecular Sciences, Mar 2024. URL: https://doi.org/10.3390/ijms25073835, doi:10.3390/ijms25073835. This article has 54 citations and is from a poor quality or predatory journal.

Citations

  1. huang2021identificationandfunctional pages 5-7
  2. marra2021drosophilaantimicrobialpeptides pages 2-4
  3. zhou2024insectantimicrobialpeptides pages 19-21
  4. daffre2004thelysozymelocus pages 1-2
  5. daffre2004thelysozymelocus pages 8-9
  6. marra2021drosophilaantimicrobialpeptides pages 4-7
  7. https://doi.org/10.1007/bf00391008
  8. https://doi.org/10.1128/mbio.00824-21
  9. https://doi.org/10.3390/ijms25073835
  10. https://doi.org/10.3390/biology10040330
  11. https://doi.org/10.3390/biology10040330,
  12. https://doi.org/10.1007/bf00391008,
  13. https://doi.org/10.1128/mbio.00824-21,
  14. https://doi.org/10.3390/ijms25073835,

OpenScientist

(LysB-hypotheses/prediction-chitinase-immune/openscientist.md)
AIGR Gene Hypothesis Deep Research β€” LysB (Q08694, DROME) OpenScientist openscientist-autonomous 6 citations 3 artifacts 2026-07-09T13:28:52.038462 citations file

AIGR Gene Hypothesis Deep Research β€” LysB (Q08694, DROME)

Focus type: computational_prediction Β· Hypothesis slug: prediction-chitinase-immune
Term under evaluation: chitinase activity (GO:0004568)
Reference context: doi:10.64898/2026.03.19.712954


Summary

The BioReason-Pro SFT model predicts that Drosophila melanogaster LysB (UniProt Q08694) has chitinase activity (GO:0004568) and two immune roles β€” negative regulation of innate immune response (GO:0045824) and defense response to Gram-negative bacterium (GO:0050829). Independent evaluation from sequence classification, domain architecture, a custom catalytic-site alignment, primary expression literature, and the current GO annotation record indicates that all three predictions are either wrong or unsupported by the physiological evidence. The overall verdict is REFUTED / OVER-ANNOTATED.

LysB is a glycoside hydrolase family 22 (GH22) C-type lysozyme (muramidase, EC 3.2.1.17) β€” not a chitinase (EC 3.2.1.14; GH18/GH19). Its molecular function is peptidoglycan hydrolysis. The "chitinase" prediction is best explained as a fold/activity misassignment arising from the well-documented, weak chito-oligosaccharide side-activity that C-type lysozymes possess, together with the general confusion between lysozyme and chitinase glycosidase folds. Physiologically, the Drosophila LysB–E cluster comprises constitutive, midgut-restricted, acidic digestive lysozymes that are transcriptionally repressed (not induced) by bacterial infection and are not expressed in fat body or hemocytes β€” the opposite of what an induced humoral immune effector or an immune regulator would look like. This makes GO:0045824 unsupported and biologically implausible for LysB, and it substantially weakens the case for GO:0050829, which exists in the GO record only as an ISS "by similarity" carry-over with no experimental basis.

For a curator, the actionable conclusion is: do not add GO:0004568 or GO:0045824; treat the existing GO:0050829 as low-confidence (ISS-only, conflicting with digestive biology) and consider flagging it for review or "non-core" status; and retain the well-supported core terms β€” GO:0003796 (lysozyme activity, MF) and GO:0005576 (extracellular region, CC) β€” ideally complemented by a BP term reflecting digestion / bacteriophagy rather than immunity.


Executive Judgment

Verdict: REFUTED / OVER-ANNOTATED.

All three predicted terms fail independent evaluation:

  • GO:0004568 (chitinase activity): Refuted. LysB is a GH22 muramidase with a conserved lysozyme catalytic dyad and no GH18/GH19 chitinase domain or active-site motif. The only "chitinase-like" property is the weak chitodextrin side-activity intrinsic to C-type lysozymes, which is captured by the canonical lysozyme catalytic-activity description and does not warrant a chitinase MF term.
  • GO:0045824 (negative regulation of innate immune response): Refuted/unsupported. No experimental or credible computational basis; contradicts the constitutive, infection-repressed, midgut-restricted expression profile.
  • GO:0050829 (defense response to Gram-negative bacterium): Weakly supported at best; present only as a single ISS "by similarity" annotation, in tension with the digestive role.

The most important caveat is that a minority of insect c-type lysozymes are genuinely dual-function (digestive + mild immune effector), so a low-level bactericidal activity for LysB cannot be fully excluded β€” but even the strongest reading of that literature would never justify a negative regulator of immunity assignment, and the Drosophila-specific expression data argue against an immune-effector role.


Key Findings

Finding 1 β€” LysB is a GH22 C-type lysozyme (EC 3.2.1.17), not a chitinase

UniProt Q08694 carries the recommended name "Lysozyme B", EC number 3.2.1.17 (lysozyme/muramidase), and the family SIMILARITY statement "Belongs to the glycosyl hydrolase 22 family." The domain architecture is exclusively C-type lysozyme with no chitinase signature whatsoever:

Resource Identifier Assignment
InterPro IPR001916 / IPR000974 Glycoside hydrolase family 22 / C-type lysozyme
Pfam PF00062 Lys (lysozyme)
CDD cd16899 LYZ_C_invert (invertebrate C-type lysozyme)
PANTHER PTHR11407 LYSOZYME C
SUPFAM SSF53955 Lysozyme-like superfamily

No GH18 or GH19 chitinase domain (e.g., Pfam PF00704 / Glyco_hydro_18, or Glyco_hydro_19) is present. The GO molecular-function annotation for Q08694 is GO:0003796 lysozyme activity, not GO:0004568 chitinase activity.

Critically, the mechanistic origin of the model's error is visible in the enzyme's own catalytic-activity description. The canonical C-type lysozyme reaction hydrolyzes the Ξ²-1,4 linkage between N-acetylmuramic acid (MurNAc) and N-acetylglucosamine (GlcNAc) in peptidoglycan β€” "and between N-acetyl-D-glucosamine residues in chitodextrins." This weak activity on chito-oligosaccharides is an intrinsic, well-known side-property of C-type lysozymes and is almost certainly the textual/feature signal that led a machine-learning model to over-predict full endochitinase activity. A weak in-vitro side-activity on short chitodextrins is not equivalent to biological chitinase activity (processive hydrolysis of insoluble chitin polymer), which is carried out by structurally distinct GH18/GH19 enzymes.

This finding is anchored in the review-level statement that "Lysozymes from family 22 of glycoside hydrolases are usually part of the defense system against bacteria" (PMID: 17825580), confirming that C-type/digestive insect lysozymes belong to GH22 β€” a family distinct from the chitinase families.

Finding 2 β€” Drosophila LysB is a constitutive midgut digestive lysozyme, not an induced immune effector

The defining expression study of the Drosophila lysozyme locus (PMID: 8159165, Daffre et al. 1994) reports that "four closely related genes, LysB, C, D and E, are all strongly expressed in the midgut of larvae and adults" and that "None of the genes is expressed in the fat body or haemocytes." In insects, the fat body and hemocytes are the principal tissues of the systemic humoral immune response; the complete absence of LysB expression there is direct evidence against a humoral/immune-effector role. The same work notes that all of these genes except LysP encode acidic proteins "highly reminiscent" of the acidic digestive lysozymes of mammalian foregut fermenters β€” a hallmark of enzymes optimized for acidic gut lumen conditions and bacteriolytic digestion.

An independent study of the same locus (PMID: 1588905, Kylsten et al. 1992) found that lysozyme transcription decreases after bacterial injection and concluded that these genes "have been recruited for the digestion of bacteria present in fermenting food." A gene whose transcription is repressed by infection and whose product acts in the gut lumen to digest dietary bacteria is behaving as a digestive enzyme, not as an inducible immune effector and certainly not as a negative regulator of the innate immune response.

Consistent with the primary literature, UniProt Q08694 states in its FUNCTION field that LysB is "Unlikely to play an active role in the humoral immune defense. May have a function in the digestion of bacteria in the food," and its TISSUE SPECIFICITY field localizes expression to the midgut with peak expression in the 3rd larval instar.

The digestive-lysozyme model is reinforced by comparative work across arthropods: housefly (Musca domestica) digestive lysozymes MdL1/MdL2 are acidic-optimum midgut enzymes (PMID: 19099150), the first crystal structure of a digestive lysozyme was solved from housefly (PMID: 17825580), and synanthropic mites use acidic digestive lysozymes to exploit bacteria as a food source, with maximal activity at the acidic pH of the gut (PMID: 18357505). These establish "acidic midgut digestive lysozyme" as a recurrent, well-characterized functional class into which Drosophila LysB clearly falls.

Finding 3 β€” Sequence analysis confirms the C-type lysozyme catalytic dyad and the absence of a chitinase active site

To test the classification directly rather than relying on database labels, an in-run global alignment (Needleman–Wunsch, implemented in NumPy) was performed between the mature LysB sequence (122 aa, after removing the signal peptide, residues 1–18) and hen egg-white lysozyme (HEWL), the archetypal GH22 C-type lysozyme:

Metric Result
Identity to HEWL 41.3% (50/121 aligned positions)
HEWL catalytic Glu35 Conserved (β†’ Glu in LysB)
HEWL catalytic Asp52 Conserved (β†’ Asp in LysB)
Cysteine count 8 (4 disulfides), matching HEWL's C-type scaffold
GH18 chitinase catalytic motif (DxxDxDxE) Absent
Enzyme classification EC 3.2.1.17 (lysozyme), not EC 3.2.1.14 (chitinase)

The conservation of both HEWL catalytic residues (the Glu general acid and the Asp that stabilizes/participates in catalysis) together with the eight-cysteine (four-disulfide) C-type lysozyme fold is diagnostic of a functional GH22 muramidase. The absence of the GH18 chitinase catalytic signature (the DxxDxDxE motif that defines the GH18 active site) is direct negative evidence against the chitinase prediction: LysB does not possess the active-site chemistry required for a genuine chitinase.

Finding 4 β€” The current GO record contains no chitinase or immune-regulation term; the sole defense term is ISS-only

A QuickGO retrieval (performed in-run) returned 6 annotations for Q08694 spanning three distinct terms:

GO term Aspect Evidence in the record
GO:0003796 lysozyme activity MF Supported four independent ways: ISS from P00697; IBA from GO_Central (PANTHER PTN004256961, including HEWL P00698); IEA from InterPro IPR000974 / EC 3.2.1.17; and ISS with reference PMID:8159165
GO:0050829 defense response to Gram-negative bacterium BP Single ISS annotation, by-similarity to UniProtKB P00697 (GO_REF:0000024, FlyBase). No experimental evidence.
GO:0005576 extracellular region CC ISS

Two facts are decisive for the curation decision:

  1. GO:0004568 (chitinase activity) is entirely absent from the current annotation set, and GO:0045824 (negative regulation of innate immune response) is entirely absent. Both predicted terms would therefore be new additions, and neither is justified by any experimental or well-founded computational evidence.
  2. The one immune-adjacent term that does exist β€” GO:0050829 β€” rests on a single ISS "by similarity" annotation with no experimental support, and it is in tension with the digestive, infection-repressed expression profile documented in Finding 2. It should be treated as low-confidence, not as corroboration of the seed hypothesis.

Mechanistic Model / Interpretation

The seed hypothesis effectively bundles two distinct claims, and both fail for the same underlying reason β€” conflation of superficially related categories:

  BioReason-Pro prediction                Reality (this analysis)
  ─────────────────────────               ────────────────────────────────
  MF: chitinase activity      ──►  GH22 C-type lysozyme (muramidase, EC 3.2.1.17)
      (GO:0004568)                  Β· Glu35/Asp52 dyad conserved (41% id to HEWL)
                     Β· 8 Cys / 4 disulfides, lysozyme fold
                     Β· NO GH18/GH19 chitinase domain or motif
                     Β· "chitinase" = weak chitodextrin SIDE-activity
                       intrinsic to C-type lysozymes β†’ misread as
                       full endochitinase

  BP: neg. reg. innate         ──►  Constitutive DIGESTIVE lysozyme
      immune response                Β· midgut-restricted; NOT in fat body/hemocytes
      (GO:0045824)                   Β· transcription REPRESSED by infection
  BP: defense vs Gram-neg.           Β· "recruited for digestion of bacteria in food"
      (GO:0050829, ISS-only)         Β· immune terms = digestive-vs-immune conflation

Molecular axis (lysozyme vs chitinase). Both lysozymes and chitinases are glycoside hydrolases that cleave Ξ²-1,4 glycosidic bonds in GlcNAc-containing polymers, so they share a substrate chemistry motif. But they are different enzyme families with different folds and active sites: GH22 (lysozyme) versus GH18/GH19 (chitinase). C-type lysozymes have a documented, weak ability to hydrolyze short chitodextrins β€” this is even written into the UniProt/Rhea catalytic-activity string for Q08694. A model trained to associate GlcNAc-hydrolysis language with "chitinase" will over-predict GO:0004568 for a lysozyme. The direct evidence (conserved lysozyme dyad, correct fold, absent chitinase motif) refutes a genuine chitinase assignment.

Physiological axis (digestive vs immune). Insect lysozymes occupy two functionally divergent niches: (i) inducible immune-effector lysozymes expressed in fat body/hemolymph and up-regulated by infection, and (ii) constitutive digestive lysozymes expressed in an acidic midgut and used to lyse and digest dietary/gut bacteria (the "bacteriophagy" strategy shared with ruminants, foregut-fermenting mammals, and acaridid mites). Drosophila LysB belongs unambiguously to class (ii): midgut-restricted, acidic, constitutive, and infection-repressed. A negative regulator of innate immunity (GO:0045824) would be a signaling/regulatory role entirely unlike a secreted gut hydrolase; nothing in the evidence supports it, and the model likely generated it by over-generalizing "lysozyme β†’ immunity" and then inverting it to fit a repression signal.

The coherent model is therefore: LysB is a secreted, extracellular (GO:0005576), acidic midgut muramidase (GO:0003796) whose biological process is the digestion of bacteria in food (bacteriophagy), not immune defense or immune regulation.


Evidence Matrix

# Citation Evidence type Direction Claim tested Key finding Context Confidence & limitations
1 UniProt Q08694 (database) Review/database Refutes chitinase; supports lysozyme Is LysB a chitinase or a lysozyme? Recommended name "Lysozyme B", EC 3.2.1.17, GH22 family; MF = GO:0003796 lysozyme activity D. melanogaster protein record High for classification; database-level, curated
2 InterPro/Pfam/CDD/PANTHER/SUPFAM (database) Structural/evolutionary (computational) Refutes chitinase Does LysB carry a chitinase domain? Exclusively C-type lysozyme domains (IPR001916/000974, PF00062, cd16899, PTHR11407, SSF53955); no GH18/GH19 Domain architecture High; concordant across 5 resources
3 PMID: 17825580 Structural/review Refutes chitinase; supports digestive lysozyme Are family-22 lysozymes a defense/digestive class distinct from chitinases? "Lysozymes from family 22 of glycoside hydrolases are usually part of the defense system against bacteria"; first digestive-lysozyme crystal structure Housefly digestive lysozyme High; direct structural family evidence
4 In-run alignment (this run) Computational Refutes chitinase Does LysB have a lysozyme dyad and lack a chitinase motif? 41.3% id to HEWL; Glu35/Asp52 conserved; 8 Cys; GH18 DxxDxDxE motif absent Mature LysB vs HEWL Moderate–high; custom NW alignment, single reference (HEWL)
5 PMID: 8159165 Localization / expression Refutes immune roles; supports digestive Where is LysB expressed? "LysB, C, D and E... strongly expressed in the midgut"; "None... expressed in the fat body or haemocytes" Larval & adult midgut High; primary study of the locus
6 PMID: 1588905 Expression / mutant-adjacent Refutes immune induction; supports digestive Is LysB induced or repressed by infection? Transcription decreases after bacterial injection; "recruited for the digestion of bacteria present in fermenting food" Drosophila gut High; primary study
7 QuickGO for Q08694 (database) Review/database Refutes both predicted terms Do current GO annotations include chitinase/immune-reg? No GO:0004568 and no GO:0045824; GO:0050829 is single ISS by-similarity; core = GO:0003796 + GO:0005576 GO annotation record High; retrieved in-run
8 PMID: 19099150 Direct assay (ortholog) Qualifies/supports digestive Do insect gut lysozymes act as acidic digestive enzymes? MdL1/MdL2 housefly midgut lysozymes, acidic pH optimum (~4.8) Housefly midgut Moderate; ortholog, not LysB itself
9 PMID: 18357505 Direct assay (comparative) Qualifies/supports digestive Is bacteriophagy a general digestive-lysozyme strategy? Acidic digestive lysozymes let mites use bacteria as food; gut-pH activity optimum Acaridid mites Moderate; comparative, not Drosophila
10 PMID: 19161941 Direct assay (ortholog) Competing/qualifies Can an insect c-type lysozyme have immune activity? Housefly MdLys mildly up-regulated by bacteria; recombinant protein inhibits Gβˆ’ and G+ bacteria Housefly midgut/fat body Moderate; shows some insect lysozymes are dual-function, but MdLys differs from LysB (expressed in fat body, infection-induced)

Evidence Base (literature summary)

Paper PMID Role in this evaluation
The lysozyme locus in Drosophila melanogaster: an expanded gene family adapted for expression in the digestive tract 8159165 Primary, decisive. LysB–E strongly midgut-expressed; none in fat body/hemocytes; acidic, digestive-lysozyme-like.
The lysozyme locus in Drosophila melanogaster: different genes are expressed in midgut and salivary glands 1588905 Primary, decisive. Transcription decreases after bacterial injection; recruited for digestion of dietary bacteria.
The crystal structure of a lysozyme c from housefly Musca domestica, the first structure of a digestive lysozyme 17825580 Confirms GH22 family placement and digestive-lysozyme structural class.
Cloning, purification and comparative characterization of two digestive lysozymes from Musca domestica larvae 19099150 Ortholog evidence: acidic-optimum midgut digestive lysozymes.
Digestive function of lysozyme in synanthropic acaridid mites enables utilization of bacteria as a food source 18357505 Comparative evidence: acidic digestive lysozyme = bacteriophagy strategy.
Molecular characterization and expression analysis of a chicken-type lysozyme gene from housefly (Musca domestica) 19161941 Competing/qualifying: some insect c-type lysozymes are dual digestive/immune β€” but MdLys (fat-body-expressed, infection-induced) differs from LysB.

GO Curation Implications

Lead (requires curator verification):

  1. GO:0004568 (chitinase activity, MF) β€” DO NOT ADD. The prediction is a fold/activity misassignment. LysB is a GH22 muramidase with a conserved lysozyme catalytic dyad and no GH18/GH19 chitinase domain or active-site motif. The only "chitinase-like" property is the intrinsic weak chitodextrin side-activity of C-type lysozymes, which is already captured by the lysozyme catalytic-activity description and does not warrant a chitinase MF term (in vitro-only, side-activity, not the biological function).

  2. GO:0045824 (negative regulation of innate immune response, BP) β€” DO NOT ADD. No experimental or credible computational support. The term is biologically implausible for a secreted digestive hydrolase and contradicts the constitutive, infection-repressed, midgut-restricted expression profile.

  3. GO:0050829 (defense response to Gram-negative bacterium, BP) β€” FLAG / treat as non-core. Present in the record only as a single ISS "by similarity" to HEWL-type P00697, with no experimental basis, and in tension with digestive biology. Recommend curator review; at minimum it should not be treated as core function, and it should not be cited as corroboration of the immune hypothesis.

  4. GO:0003796 (lysozyme activity, MF) β€” RETAIN (core). Well supported by four independent evidence lines (ISS, IBA, IEA/InterPro-EC, and ISS to PMID:8159165) and by the in-run catalytic-dyad analysis. This is the correct primary molecular function.

  5. GO:0005576 (extracellular region, CC) β€” RETAIN. Consistent with a secreted gut lysozyme.

  6. Consider ADDING a digestion-focused BP term (curator lead): a term reflecting digestion / catabolism of bacterial cell wall in the gut / bacteriophagy would more accurately capture the biological process than any immune term. Candidate directions include a peptidoglycan catabolic process or digestion term; the exact choice should be curator-verified against GO structure and the PMID:8159165 / PMID:1588905 evidence.

Aspect summary: MF = lysozyme activity (retain), not chitinase (reject). BP = digestion/bacteriophagy (add, curator-verify), not immune regulation (reject) and not defense-response as core (downgrade). CC = extracellular region (retain).


Mechanistic Scope

The immediate molecular function under test is glycoside-hydrolase activity on a GlcNAc-containing polymer. The direct gene-product activity of LysB is muramidase/lysozyme activity β€” hydrolysis of the MurNAc–GlcNAc Ξ²-1,4 bond in bacterial peptidoglycan β€” as established by family classification, domain content, the conserved Glu/Asp catalytic dyad, and EC 3.2.1.17. This is distinct from chitinase activity, which requires the GH18/GH19 fold and active site that LysB lacks.

Everything in the immune framing of the seed hypothesis is either downstream/indirect or absent:
- "Defense response to Gram-negative bacterium" is an inferred phenotype-level consequence, imported by similarity, not a demonstrated function of LysB.
- "Negative regulation of innate immune response" is a regulatory/signaling process category with no mechanistic link to a secreted digestive hydrolase; there is no evidence LysB participates in immune signaling.
- The digestive role (lysing dietary bacteria in the acidic midgut) is the direct physiological deployment of the muramidase activity β€” a nutritional/digestive process, not an immune-defense process, even though the underlying chemistry (bacteriolysis) is shared with immune lysozymes.


Conflicts and Alternatives

  • Paralog / family carry-over confusion. The Drosophila lysozyme locus contains a tandem cluster (LysB–E, plus LysP, LysS, etc.). Annotations and predictions can bleed across paralogs and across the broader "lysozyme/glycosidase" family. The GO:0050829 ISS to HEWL (P00697) is a concrete example of defense-response carry-over from a canonical immune lysozyme to a digestive one.

  • Dual-function orthologs are real but do not rescue the immune prediction. Housefly MdLys (PMID: 19161941) is expressed in midgut and fat body, is mildly infection-induced, and its recombinant protein inhibits bacteria β€” i.e., some insect c-type lysozymes are genuinely dual digestive/immune. This is a legitimate competing consideration. However, it does not apply to Drosophila LysB, which β€” unlike MdLys β€” is not expressed in fat body/hemocytes and is repressed (not induced) by infection (PMID: 8159165; PMID: 1588905). Even the strongest immune interpretation would be a mild bactericidal effector activity, never negative regulation of the immune response (GO:0045824).

  • Weak in-vitro chitodextrin activity vs biological chitinase. C-type lysozymes can slowly hydrolyze short chito-oligosaccharides. Treating this in-vitro side-activity as a biological chitinase function would be an over-annotation; the physiological substrate is peptidoglycan.

  • Organism/tissue specificity. Evidence supporting digestion comes partly from orthologs (housefly, mites). While the Drosophila-specific expression data are decisive against the immune-effector/regulator interpretation, direct enzymatic assays of purified Q08694 protein are not in the reviewed literature set (see Knowledge Gaps).


Limitations and Knowledge Gaps

  1. No direct enzymatic assay of purified LysB (Q08694). Checked: the primary literature reviewed here characterizes the locus expression (PMID:8159165, 1588905) and orthologous digestive lysozymes (housefly, mites), but not a purified recombinant LysB kinetic assay. This matters because the definitive discriminator between lysozyme and chitinase, and between digestive and immune roles, is a direct activity/pH-profile assay on the LysB protein. Resolution: recombinant expression + muramidase vs chitinase activity assays and an acidic-pH-optimum profile.

  2. Alignment used a single reference (HEWL). The in-run NW alignment (41% identity, conserved dyad) is robust for classification but is a custom implementation against one archetype. Resolution: a multiple-sequence alignment across GH22 members and a structural superposition (e.g., AlphaFold model vs HEWL and vs a GH18 chitinase) would strengthen the fold assignment. Structural tools (Phenix/superpose) were available but not required given the concordant sequence/domain evidence.

  3. GO:0050829 provenance. It is ISS-by-similarity to P00697; the exact rationale and whether FlyBase intends it as core is not fully resolved from the record alone. Resolution: curator inspection of GO_REF:0000024 and the FlyBase gene report.

  4. No in-run structural confidence metrics (pLDDT/PAE). An AlphaFold confidence check was not run; it would add independent support for the lysozyme fold but is not necessary to reach the verdict.

  5. Reference doi:10.64898/2026.03.19.712954 (the source of the BioReason-Pro prediction) was not independently retrieved; the evaluation treats the prediction as stated in the seed context.


Discriminating Tests

The following would most efficiently separate the seed hypothesis from the digestive-lysozyme interpretation:

  1. Enzymatic assay of recombinant LysB. Measure muramidase activity on Micrococcus lysodeikticus cell walls vs endochitinase activity on a fluorogenic chitin substrate (e.g., 4-MU-chitotrioside) and on insoluble/colloidal chitin. Prediction: strong acidic-pH muramidase activity, negligible/only weak short-chitodextrin activity, no processive chitin degradation. This directly refutes GO:0004568.

  2. pH–activity profile. Digestive insect lysozymes have acidic optima (~4.8, cf. housefly MdL1/MdL2, PMID: 19099150). An acidic optimum supports a gut-digestive role.

  3. Infection-challenge transcriptomics. RNA-seq/qPCR of LysB after septic injury vs oral bacterial feeding, in gut vs fat body. Prediction: no fat-body induction, repression in gut β€” inconsistent with an immune effector and with a negative regulator of immunity.

  4. Loss-of-function phenotype. LysB knockdown/knockout scored for gut bacterial digestion/clearance and nutritional phenotype vs systemic immune-response readouts (AMP induction, survival to infection). Prediction: digestive/nutritional phenotype, not altered immune signaling.

  5. Structural superposition. AlphaFold model of LysB superposed on HEWL (GH22) and on a GH18 chitinase (TIM-barrel). Prediction: RMSD-close to HEWL, fold-incompatible with the chitinase TIM-barrel.

  6. Comparative catalytic-residue mapping across the Drosophila Lys cluster and canonical GH18/GH19 chitinases to confirm the absence of the chitinase catalytic glutamate context in all LysB-family members.


Proposed Follow-up Actions (Curation Leads)

All items are leads requiring curator verification.

Candidate action changes
- Reject proposed GO:0004568 (chitinase activity) and GO:0045824 (negative regulation of innate immune response) β€” do not add.
- Downgrade / flag GO:0050829 (defense response to Gram-negative bacterium) as ISS-only, non-core, conflicting with digestive expression data.
- Retain GO:0003796 (lysozyme activity, MF) and GO:0005576 (extracellular region, CC) as core.
- Consider adding a digestion/bacteriophagy BP term (curator to select the exact term; e.g., a peptidoglycan catabolic / digestion term).

Candidate references with snippets to verify
- PMID: 8159165: "four closely related genes, LysB, C, D and E, are all strongly expressed in the midgut of larvae and adults" and "None of the genes is expressed in the fat body or haemocytes." β†’ supports digestive, refutes immune-effector.
- PMID: 1588905: "have been recruited for the digestion of bacteria present in fermenting food" β†’ supports digestive; note transcription decreases after bacterial injection.
- PMID: 17825580: "Lysozymes from family 22 of glycoside hydrolases are usually part of the defense system against bacteria" β†’ confirms GH22 family placement (distinct from chitinase families).
- UniProt Q08694 FUNCTION: "Unlikely to play an active role in the humoral immune defense. May have a function in the digestion of bacteria in the food."

Suggested curator questions
- Should GO:0050829 remain given it is ISS-only and conflicts with midgut-digestive, infection-repressed biology?
- Is there an appropriate GO BP term for gut bacteriophagy/digestion that should replace the immune framing?
- Does FlyBase hold any direct enzymatic data on Q08694 that would confirm the acidic muramidase profile?

Suggested experiments β€” see Discriminating Tests above (recombinant muramidase-vs-chitinase assay; acidic pH profile; challenge transcriptomics; LOF phenotype; structural superposition).


Bottom Line

LysB (Q08694) is a GH22 C-type digestive lysozyme (muramidase, EC 3.2.1.17). The BioReason-Pro predictions of chitinase activity (GO:0004568) and negative regulation of innate immune response (GO:0045824) are refuted / over-annotated: the chitinase call is a fold/side-activity misassignment, and the immune-regulation call conflates a constitutive, infection-repressed, midgut-restricted digestive enzyme with an immune regulator. The pre-existing GO:0050829 annotation is ISS-only and should be treated as low-confidence, non-core. Curators should retain GO:0003796 (lysozyme activity) and GO:0005576 (extracellular region) and consider adding a digestion/bacteriophagy BP term rather than any immune term.

Artifacts

πŸ“š Additional Documentation

Bioreason Rl Predictions

(LysB-bioreason-rl-predictions.md)

BioReason Chat Export

Exported on March 22, 2026 at 02:11 AM


Organism: Drosophila melanogaster

Sequence:

MKAFIVLVALALAAPALGRTMDRCSLAREMSNLGVPRDQLARWACIAEHESSYRTGVVGPENYNGSNDYGIFQINDYYWCAPPSGRFSYNECGLSCNALLTDDITHSVRCAQKVLSQQGWSAWSTWHYCSGWLPSIDDCF

Thinking Trace

I begin with the InterPro architecture. The N-terminal half carries IPR001916 (Glycoside hydrolase, family 22, residues 6–140), which defines a classical lysozyme/glycoside-hydrolase scaffold that catalyzes cleavage of Ξ²-1,4 linkages in bacterial peptidoglycan. Nested within this, IPR000974 (Glycoside hydrolase, family 22, lysozyme, residues 20–127) specifies the lysozyme lineage that targets peptidoglycan sacculi and typically uses a conserved acid/base catalytic apparatus to hydrolyze the glycan backbone. The architecture is reinforced by IPR023346 (Lysozyme-like domain superfamily, residues 20–135), confirming a lysozyme-like fold that stabilizes the active site geometry required for polysaccharide hydrolysis. A short internal motif, IPR019799 (Glycoside hydrolase family 22 domain, residues 92–110), marks the catalytic core segment characteristic of GH22 enzymes. The ordered layoutβ€”an extended GH22 framework with an embedded catalytic stripβ€”causally establishes a lysozyme-type glycosidase that cleaves bacterial cell-wall polymers.

This domain ensemble dictates molecular function. The GH22/lysozyme fold and internal catalytic region confer lysozyme activity, a hydrolase function that breaks Ξ²-1,4 O-glycosidic bonds in peptidoglycan; thus the primary molecular function is lysozyme activity (GO:0003796), a specific instance of glycosidase chemistry encoded by GH22.

From this chemistry, the biological process follows. Hydrolysis of peptidoglycan is a core step in antibacterial defense pathways that culminate in cell-wall weakening and lysis, and it also serves as a catabolic route for cell-wall turnover. Therefore, the enzyme contributes to antibacterial humoral defense and peptidoglycan catabolism that supports innate immunity in the insect host.

Cellular localization is inferred from the soluble GH22 architecture and the absence of transmembrane segments or secretion signals in the provided features; this fold typically forms secreted or luminal enzymes that act extracellularly. In insects, lysozymes often function in hemolymph and epithelial secretions where microbes are encountered. Consequently, a soluble extracellular localization is most consistent, pointing to the extracellular region as the operating site.

Mechanistically, the protein likely binds peptidoglycan via a positively charged groove formed by the lysozyme-like fold and hydrolyzes the glycan chain using a catalytic acid/base dyad stabilized by the GH22 core. In vivo, it probably cooperates with other innate immune factorsβ€”such as antimicrobial peptides and peroxidasesβ€”that permeabilize or oxidative-modify bacterial envelopes, thereby exposing peptidoglycan to this hydrolase. I hypothesize transient assemblies with pattern-recognition and immune effector modules that position the enzyme at pathogen surfaces to maximize catalytic access and amplify bacteriolytic outcomes.

Functional Summary

A soluble lysozyme-class glycosidase in fruit fly that hydrolyzes bacterial cell-wall polymers, thereby contributing to innate antibacterial defense and peptidoglycan turnover. Its lysozyme-like fold and catalytic core enable cleavage of Ξ²-1,4-linked glycans, and the enzyme most plausibly operates in extracellular fluids where microbes are encountered, acting in concert with other humoral immune factors to weaken and dismantle bacterial envelopes.

UniProt Summary

Lysozymes have primarily a bacteriolytic function; those of animals and plants also function in the defense response to infection.

InterPro Domains

  • Glycoside hydrolase, family 22 (IPR001916, family) β€” residues 6-140
  • Glycoside hydrolase, family 22, lysozyme (IPR000974, family) β€” residues 20-127
  • Lysozyme-like domain superfamily (IPR023346, homologous_superfamily) β€” residues 20-135
  • Glycoside hydrolase family 22 domain (IPR019799, domain) β€” residues 92-110

GO Terms

Molecular Function: molecular_function (GO:0003674), catalytic activity (GO:0003824), peptidoglycan muralytic activity (GO:0061783), hydrolase activity (GO:0016787), hydrolase activity, acting on glycosyl bonds (GO:0016798), lysozyme activity (GO:0003796), hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553), chitinase activity (GO:0004568)

Biological Process: biological_process (GO:0008150), biological regulation (GO:0065007), response to stimulus (GO:0050896), regulation of biological process (GO:0050789), biological process involved in interspecies interaction between organisms (GO:0044419), negative regulation of biological process (GO:0048519), response to external stimulus (GO:0009605), negative regulation of immune system process (GO:0002683), response to biotic stimulus (GO:0009607), regulation of response to stimulus (GO:0048583), regulation of immune system process (GO:0002682), response to stress (GO:0006950), response to other organism (GO:0051707), negative regulation of response to stimulus (GO:0048585), negative regulation of immune response (GO:0050777), regulation of response to biotic stimulus (GO:0002831), regulation of immune response (GO:0050776), response to external biotic stimulus (GO:0043207), regulation of response to stress (GO:0080134), response to bacterium (GO:0009617), defense response (GO:0006952), regulation of response to external stimulus (GO:0032101), negative regulation of response to biotic stimulus (GO:0002832), defense response to other organism (GO:0098542), negative regulation of defense response (GO:0031348), negative regulation of response to external stimulus (GO:0032102), regulation of defense response (GO:0031347), regulation of innate immune response (GO:0045088), defense response to bacterium (GO:0042742), negative regulation of innate immune response (GO:0045824), defense response to Gram-negative bacterium (GO:0050829)

Cellular Component: cellular_component (GO:0005575), cellular anatomical entity (GO:0110165), extracellular region (GO:0005576), extracellular space (GO:0005615)


Generated by BioReason

Bioreason Rl Review

(LysB-bioreason-rl-review.md)

BioReason-Pro RL Review: LysB (DROME)

Source: LysB-bioreason-rl-predictions.md

  • Correctness: 3/5
  • Completeness: 3/5

Functional Summary Review

The BioReason summary states:

A soluble lysozyme-class glycosidase in fruit fly that hydrolyzes bacterial cell-wall polymers, thereby contributing to innate antibacterial defense and peptidoglycan turnover. Its lysozyme-like fold and catalytic core enable cleavage of beta-1,4-linked glycans, and the enzyme most plausibly operates in extracellular fluids where microbes are encountered, acting in concert with other humoral immune factors to weaken and dismantle bacterial envelopes.

The molecular function identification is correct: LysB is indeed a c-type lysozyme (GH22) with lysozyme activity (GO:0003796). The curated review confirms this.

Critical error -- immune defense framing: The summary describes LysB as "contributing to innate antibacterial defense" and "acting in concert with other humoral immune factors." The curated review explicitly contradicts this: LysB is "primarily expressed in the digestive tract (midgut of larvae and adults) where it functions in the digestion of bacteria from food and in shaping gut microbiota composition. LysB is not expressed in fat body or hemocytes and is actually repressed, not induced, upon systemic bacterial infection" (PMID:8159165). The curated review modifies the defense response annotations, proposing replacement with digestion (GO:0007586).

The summary states it "operates in extracellular fluids where microbes are encountered" -- while technically LysB is secreted and extracellular, the relevant extracellular space is the gut lumen, not the hemolymph. The "humoral immune factors" framing is specifically contradicted by the literature.

Missing digestive function context: The curated core function description places LysB in the midgut (UBERON:0001045) with a primary role in digestion, analogous to ruminant stomach lysozymes that digest symbiotic bacteria. This biological context is entirely absent from the BioReason summary.

Acidic protein character: The curated review notes all lysozyme genes except LysP "encode acidic proteins, in contrast to the strongly basic 'typical' lysozymes," which is functionally relevant for gut enzyme adaptation. Not mentioned by BioReason.

Comparison with interpro2go:

The ai-review.yaml does not contain GO_REF:0000002 annotations for LysB (lysozyme activity comes via IBA and IEA/GO_REF:0000120). BioReason's reasoning from GH22 domain architecture produces the same functional conclusion as interpro2go-based annotations: lysozyme activity and antibacterial defense. Critically, BioReason makes the same error as the IEA annotations from keyword mapping (GO_REF:0000043) -- assigning defense response to bacterium (GO:0042742) and defense response to Gram-negative bacterium (GO:0050829) -- which the curated review flags as inappropriate for a digestive lysozyme. Domain architecture alone cannot distinguish immune from digestive function.

Notes on thinking trace

The trace correctly identifies the GH22 family, catalytic residues, and lysozyme-like fold. The inference about signal peptide and extracellular secretion is reasonable. The hypothesized cooperation with "antimicrobial peptides and peroxidases" reflects an immune defense assumption that is incorrect for LysB.

πŸ“„ View Raw YAML

id: Q08694
gene_symbol: LysB
product_type: PROTEIN
status: DRAFT
taxon:
  id: NCBITaxon:7227
  label: Drosophila melanogaster
description: >
  LysB encodes Lysozyme B, a secreted c-type lysozyme (glycosyl hydrolase family 22)
  that hydrolyzes the beta-1,4 glycosidic bond between N-acetylmuramic acid and
  N-acetylglucosamine in bacterial peptidoglycan. Unlike classical immune lysozymes
  that function in the hemolymph, LysB is primarily expressed in the digestive tract
  (midgut of larvae and adults) where it functions in the digestion of bacteria from
  food and in shaping gut microbiota composition. LysB is not expressed in fat body
  or hemocytes and is actually repressed, not induced, upon systemic bacterial infection,
  supporting its role as a digestive rather than immune enzyme (PMID:8159165, Marra et al. 2021).
existing_annotations:
- term:
    id: GO:0003796
    label: lysozyme activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >
      LysB is a bona fide c-type lysozyme belonging to glycosyl hydrolase family 22,
      with conserved catalytic residues and characteristic domain structure. The IBA
      annotation is based on phylogenetic inference from well-characterized lysozymes
      including chicken lysozyme (UniProtKB:P00698). The enzymatic activity is supported
      by the conserved catalytic Glu/Asp residues (positions 50 and 68 in LysB) and
      demonstrated ex vivo lysozyme activity in gut extracts from Drosophila (Marra et al. 2021).
    action: ACCEPT
    reason: >
      Core molecular function of LysB. The GH22 family assignment, conserved catalytic
      residues, and functional validation through gut lysozyme activity assays all
      support this annotation. IBA provides strong phylogenetic evidence.
    supported_by:
      - reference_id: PMID:8159165
        supporting_text: "four closely related genes, LysB, C, D and E, are all strongly expressed in the midgut of larvae and adults"
      - reference_id: file:DROME/LysB/LysB-deep-research-falcon.md
        supporting_text: "engineered deletion (LysB-PD) removing LysC and four gut-expressed lysozyme genes (including LysB) reduced ex vivo lysozyme activity (peptidoglycan digestion)"

- term:
    id: GO:0003796
    label: lysozyme activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >
      This IEA annotation is based on InterPro domain mapping (IPR000974) and EC number
      assignment (EC:3.2.1.17). It correctly identifies LysB as having lysozyme
      (1,4-beta-N-acetylmuramidase) activity.
    action: ACCEPT
    reason: >
      Redundant with IBA annotation but correctly assigned based on domain architecture.
      The InterPro glycosyl hydrolase 22 domains (IPR001916, IPR000974) and EC:3.2.1.17
      assignment are accurate for this protein.
    supported_by:
      - reference_id: UniProt:Q08694
        supporting_text: "Belongs to the glycosyl hydrolase 22 family"

- term:
    id: GO:0003824
    label: catalytic activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >
      This is a very general parent term for lysozyme activity. While technically
      correct, it provides no additional information beyond what is captured by the
      more specific lysozyme activity annotation.
    action: ACCEPT
    reason: >
      Automatically inferred from UniProtKB keyword mapping. While overly general,
      this hierarchical annotation is not incorrect and serves as a parent term
      for the more informative lysozyme activity annotations.
    supported_by:
      - reference_id: UniProt:Q08694
        supporting_text: "RecName: Full=Lysozyme B; EC=3.2.1.17"

- term:
    id: GO:0016787
    label: hydrolase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >
      Parent term annotation derived from hydrolase keyword. LysB is indeed a hydrolase
      that cleaves glycosidic bonds in peptidoglycan.
    action: ACCEPT
    reason: >
      Correct hierarchical annotation. More specific terms (lysozyme activity,
      hydrolase activity acting on glycosyl bonds) are also present.
    supported_by:
      - reference_id: UniProt:Q08694
        supporting_text: "Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan"

- term:
    id: GO:0016798
    label: hydrolase activity, acting on glycosyl bonds
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >
      Appropriately specific parent term for lysozyme activity. LysB hydrolyzes
      glycosyl bonds in bacterial peptidoglycan.
    action: ACCEPT
    reason: >
      Correct intermediate-level annotation. This is the appropriate parent for
      lysozyme activity (GO:0003796) and accurately describes the bond type cleaved.
    supported_by:
      - reference_id: UniProt:Q08694
        supporting_text: "Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan"

- term:
    id: GO:0031640
    label: killing of cells of another organism
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >
      This annotation is derived from the UniProtKB Antimicrobial keyword (KW-0081).
      While lysozymes can technically kill bacteria by degrading their cell walls,
      this annotation requires careful evaluation for LysB specifically. The primary
      literature (PMID:8159165) explicitly states that LysB is "unlikely to play an
      active role in the humoral immune defense" and is adapted for "digestion of
      bacteria in the food." The deep research shows LysB functions in gut microbiota
      regulation rather than bactericidal immunity. However, lysozyme-mediated
      peptidoglycan hydrolysis does result in bacterial cell death, making this
      annotation technically accurate even for digestive lysozymes. This represents
      a legitimate SPKW annotation for lysozymes.
    action: ACCEPT
    reason: >
      This is a LEGITIMATE SPKW annotation for lysozymes. While the primary biological
      role of LysB is digestive/microbiota regulation rather than immune defense,
      the enzymatic action of lysozyme (peptidoglycan hydrolysis) does result in
      bacterial cell killing. The annotation captures the molecular outcome of
      lysozyme activity. The UniProt Antimicrobial keyword is appropriately applied
      to bacteriolytic enzymes. This is an example of correct SPKW contribution where
      the keyword accurately reflects the biochemical consequence of enzyme activity.
    additional_reference_ids:
      - PMID:8159165
      - file:DROME/LysB/LysB-deep-research-falcon.md
    supported_by:
      - reference_id: PMID:8159165
        supporting_text: "probably involved in the digestion of bacteria in the food"
      - reference_id: UniProt:Q08694
        supporting_text: "Antimicrobial; Bacteriolytic enzyme"

- term:
    id: GO:0042742
    label: defense response to bacterium
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >
      This annotation is derived from the Antimicrobial keyword. However, the
      primary literature strongly suggests LysB does NOT function in classical
      immune defense. PMID:8159165 states LysB is "unlikely to play an active role
      in the humoral immune defense" and is not expressed in immune tissues (fat body,
      hemocytes). Furthermore, LysB and related gut lysozymes are REPRESSED, not
      induced, after systemic bacterial infection. The Marra et al. 2021 study shows
      gut lysozymes function in microbiota regulation and homeostasis rather than
      pathogen defense. While lysozymes can contribute to defense by killing bacteria,
      the specific biological context of LysB is digestive/homeostatic rather than
      defensive.
    action: MODIFY
    reason: >
      This annotation may overstate the immune defense role of LysB. The literature
      explicitly indicates LysB is adapted for digestive function and is not part of
      the humoral immune response. Consider whether a more accurate process annotation
      would capture the microbiota regulation function. However, there is no ideal
      GO term for "digestion of bacteria" or "gut microbiota regulation by enzyme."
      The term could be retained with the understanding that it represents a broader
      interpretation, but marking as potentially over-annotated.
    proposed_replacement_terms:
      - id: GO:0007586
        label: digestion
    additional_reference_ids:
      - PMID:8159165
    supported_by:
      - reference_id: UniProt:Q08694
        supporting_text: "Unlikely to play an active role in the humoral immune defense. May have a function in the digestion of bacteria in the food."
      - reference_id: PMID:8159165
        supporting_text: "The LysD-like genes and LysS are strongly repressed in artificially infected animals"
      - reference_id: PMID:8159165
        supporting_text: "None of the genes is expressed in the fat body or haemocytes"

- term:
    id: GO:0003796
    label: lysozyme activity
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      ISS annotation based on sequence similarity to characterized lysozymes,
      using UniProtKB:P00697 (turkey lysozyme) as reference. This supports the
      enzymatic function annotation.
    action: ACCEPT
    reason: >
      Valid ISS annotation supporting the core molecular function. The sequence
      similarity to well-characterized vertebrate lysozymes is well-established.
    supported_by:
      - reference_id: UniProt:Q08694
        supporting_text: "Belongs to the glycosyl hydrolase 22 family"

- term:
    id: GO:0005615
    label: extracellular space
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      ISS annotation indicating extracellular localization. This is consistent with
      LysB being a secreted protein with a signal peptide (residues 1-18). The protein
      is predicted to be secreted into the gut lumen where it acts on bacteria.
    action: ACCEPT
    reason: >
      Appropriate cellular component annotation. LysB has a signal peptide and is
      secreted. Expression in midgut and detection in haemolymph at low levels
      support extracellular localization (PMID:8159165). For a gut lysozyme, the
      extracellular space would be the gut lumen.
    supported_by:
      - reference_id: file:DROME/LysB/LysB-deep-research-falcon.md
        supporting_text: "Insect c-type lysozymes are secreted proteins with N-terminal signal peptides"
      - reference_id: UniProt:Q08694
        supporting_text: "AltName: Full=1,4-beta-N-acetylmuramidase B; Flags: Precursor"

- term:
    id: GO:0050829
    label: defense response to Gram-negative bacterium
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >
      ISS annotation based on similarity to vertebrate lysozymes. This is problematic
      for several reasons. First, LysB is unlikely to function in immune defense as
      stated explicitly in PMID:8159165. Second, classical c-type lysozymes are
      typically more effective against Gram-positive bacteria (which have exposed
      peptidoglycan) than Gram-negative bacteria (which have an outer membrane
      protecting the peptidoglycan layer). The annotation may be transferred from
      a vertebrate lysozyme in a different functional context.
    action: MODIFY
    reason: >
      This annotation is likely inappropriate for LysB. The literature indicates LysB
      is not an immune defense protein. Additionally, classical lysozymes require
      outer membrane permeabilization to act on Gram-negative bacteria. If a defense
      annotation is retained, it should be at the more general "defense response to
      bacterium" level, though even that is questionable given the explicit statements
      in the primary literature that LysB does not function in immune defense.
    proposed_replacement_terms:
      - id: GO:0007586
        label: digestion
    additional_reference_ids:
      - PMID:8159165
    supported_by:
      - reference_id: UniProt:Q08694
        supporting_text: "Unlikely to play an active role in the humoral immune defense. May have a function in the digestion of bacteria in the food."
      - reference_id: PMID:8159165
        supporting_text: "None of the genes is expressed in the fat body or haemocytes"

- term:
    id: GO:0003796
    label: lysozyme activity
  evidence_type: ISS
  original_reference_id: PMID:8159165
  review:
    summary: >
      This annotation cites PMID:8159165 (Daffre et al. 1994) which characterized
      the Drosophila lysozyme gene family. While the paper establishes that LysB
      is a lysozyme gene in the 61F locus, it primarily characterizes expression
      patterns rather than providing direct enzymatic assays for LysB specifically.
      However, the sequence analysis and family membership strongly support
      lysozyme activity.
    action: ACCEPT
    reason: >
      Core molecular function annotation supported by the primary characterization
      paper. The paper establishes LysB as part of an expanded lysozyme gene family
      with digestive tract expression.
    supported_by:
      - reference_id: PMID:8159165
        supporting_text: "four closely related genes, LysB, C, D and E, are all strongly expressed in the midgut of larvae and adults"

references:
- id: PMID:8159165
  title: 'The lysozyme locus in Drosophila melanogaster: an expanded gene family adapted for expression in the digestive tract.'
  findings:
    - statement: LysB is one of seven lysozyme genes at the 61F locus
      supporting_text: "we have now characterized all six lysozyme genes in the cloned part of the lysozyme locus at 61F, and a seventh gene that maps to the same chromosomal location"
    - statement: LysB, LysC, LysD, and LysE are strongly expressed in midgut of larvae and adults
      supporting_text: "four closely related genes, LysB, C, D and E, are all strongly expressed in the midgut of larvae and adults"
    - statement: None of the lysozyme genes is expressed in fat body or hemocytes
      supporting_text: "None of the genes is expressed in the fat body or haemocytes"
    - statement: LysD-like genes are repressed after systemic bacterial infection
      supporting_text: "The LysD-like genes and LysS are strongly repressed in artificially infected animals"
    - statement: The lysozymes are unlikely to play a role in humoral immune defense
      supporting_text: "rather than being a component of the haemolymph, the Drosophila lysozymes are found mainly in the digestive tract"
    - statement: The function is probably digestion of bacteria in food
      supporting_text: "probably involved in the digestion of bacteria in the food"
    - statement: All genes except LysP encode acidic proteins (unlike typical basic lysozymes)
      supporting_text: "Furthermore all genes, except LysP, encode acidic proteins, in contrast to the strongly basic \"typical\" lysozymes"
    - statement: Expression pattern is reminiscent of ruminant stomach lysozymes that digest symbiotic bacteria
      supporting_text: "highly reminiscent of the situation in ruminants, where the lysozymes have been recruited for the digestion of symbiotic bacteria in the stomach"
- id: file:DROME/LysB/LysB-deep-research-falcon.md
  title: 'Deep research summary for LysB from Falcon AI'
  findings:
    - statement: Deletion of gut lysozymes (LysB-PD) reduces ex vivo muramidase activity
      supporting_text: "engineered deletion (LysB-PD) removing LysC and four gut-expressed lysozyme genes (including LysB) reduced ex vivo lysozyme activity (peptidoglycan digestion)"
    - statement: Lysozyme loss increases stochasticity of gut microbiota composition
      supporting_text: "loss of lysozymes (LysB-PD deletion removing LysB, LysD, LysE, LysP, LysC) increased stochasticity and altered community structure"
    - statement: Total bacterial load is not significantly affected by lysozyme loss
      supporting_text: "total bacterial load changes were not significant, indicating lysozymes contribute primarily to composition control rather than bulk bacterial burden"
    - statement: Lysozymes contribute to microbiota community structure regulation
      supporting_text: "lysozymes, while secondary to AMPs in effect size, are necessary to stabilize gut community structure"
    - statement: Gut lysozymes are induced by microbiota colonization (not systemic infection)
      supporting_text: "gut colonization by microbiota induces gut lysozyme expression, aligning them with epithelial homeostasis rather than systemic acute-phase effectors"
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings:
    - statement: Maps Antimicrobial keyword (KW-0081) to GO:0031640 (killing of cells of another organism)
    - statement: Maps Antimicrobial keyword to GO:0042742 (defense response to bacterium)
    - statement: Maps Hydrolase keyword to GO:0016787 and children
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []

core_functions:
  - description: >
      LysB is a c-type lysozyme (GH22 family) that hydrolyzes beta-1,4 glycosidic
      bonds between N-acetylmuramic acid and N-acetylglucosamine in bacterial
      peptidoglycan. It is expressed in the midgut where it functions in digestion
      of bacteria from food and regulation of gut microbiota composition.
    molecular_function:
      id: GO:0003796
      label: lysozyme activity
    directly_involved_in:
      - id: GO:0007586
        label: digestion
    locations:
      - id: GO:0005576
        label: extracellular region
    anatomical_locations:
      - id: UBERON:0001045
        label: midgut
    supported_by:
      - reference_id: PMID:8159165
        supporting_text: "four closely related genes, LysB, C, D and E, are all strongly expressed in the midgut of larvae and adults"
      - reference_id: UniProt:Q08694
        supporting_text: "May have a function in the digestion of bacteria in the food"

proposed_new_terms:
  - proposed_name: digestion of microorganism
    proposed_definition: >
      The process of breaking down microorganisms (bacteria, fungi, etc.) as food or
      for nutrient acquisition, typically through enzymatic degradation in the
      digestive tract. This process is distinct from immune-mediated killing of
      microorganisms.
    justification: >
      There is currently no GO term specifically for the enzymatic digestion
      of bacteria/microorganisms as food or for microbiota regulation. This
      would be distinct from immune-mediated killing. Terms like "digestion"
      are broad, and "defense response to bacterium" implies immune function.
      A term capturing the digestive/symbiotic processing of bacteria would
      better annotate genes like LysB.
    proposed_parent:
      id: GO:0007586
      label: digestion

suggested_questions:
  - question: What is the relative contribution of individual lysozyme genes (LysB, LysC, LysD, LysE) to gut function?
  - question: Does LysB have any role in host defense in specific contexts (e.g., gut epithelial immunity)?
  - question: What is the substrate specificity of LysB - is it more effective against certain bacterial species?

suggested_experiments:
  - description: Single-gene CRISPR knockout of LysB to distinguish its function from other gut lysozymes
    hypothesis: LysB knockout alone will have measurable effects on gut microbiota composition
  - description: Direct enzymatic assays with purified LysB protein against different bacterial peptidoglycans
    hypothesis: LysB will show muramidase activity with potential substrate preferences
  - description: Comparison of LysB activity at acidic gut pH vs neutral pH
    hypothesis: LysB may have optimal activity at gut pH consistent with its digestive role